Literature DB >> 15505991

Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men.

F Giugliano1, K Esposito, C Di Palo, M Ciotola, G Giugliano, R Marfella, M D'Armiento, D Giugliano.   

Abstract

Erectile and endothelial dysfunction may have some shared pathways through a defect in nitric oxide activity. We evaluated associations between erectile function, endothelial function and markers of systemic vascular inflammation in 80 obese men, aged 35-55 yr, divided into two equal groups according to the presence/absence of erectile dysfunction. Compared with non-obese age-matched men [no.=50, body mass index (BMI)=24 +/- 1], obese men (all) had impaired indices of endothelial function as suggested by the reduced mean blood pressure and platelet aggregation responses to L-arginine, and higher circulating concentrations of the proinflammatory cytokines interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-18 (IL-18), as well as C-reactive protein (CRP). The mean erectile function score was 14 +/- 4 (range 7-19) in obese men with erectile dysfunction and 23.5 +/- 1 (range 22-25) in obese men without erectile dysfunction. Endothelial function showed a greater impairment in impotent obese men as compared with potent obese men. The mean blood pressure and platelet aggregation decreases following L-arginine were -1.5 +/- 1.1 mmHg and -1.1 +/- 1.2%, respectively, in obese men with erectile dysfunction, and -3.4 +/- 1.2 mmHg and -5.6 +/- 2.1%, respectively, in obese men without erectile dysfunction (p < 0.01). Circulating CRP levels were significantly higher in obese men with erectile dysfunction as compared with obese men without erectile dysfunction (p < 0.05). Erectile function score was positively associated with mean blood pressure responses to L-arginine and negatively associated with BMI, waist-to-hip ratio (WHR), and CRR Erectile and endothelial dysfunction associate in obese men and may contribute to their raised cardiovascular risk through impaired nitric oxide availability elicited by a low-grade inflammatory state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505991     DOI: 10.1007/BF03347500

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?

Authors:  M E Sullivan; C S Thompson; M R Dashwood; M A Khan; J Y Jeremy; R J Morgan; D P Mikhailidis
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

2.  Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study.

Authors:  John F Keaney; Martin G Larson; Ramachandran S Vasan; Peter W F Wilson; Izabella Lipinska; Diane Corey; Joseph M Massaro; Patrice Sutherland; Joseph A Vita; Emelia J Benjamin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

3.  Obesity and oxidative stress: a direct link to CVD?

Authors:  Jane V Higdon; Balz Frei
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-01       Impact factor: 8.311

4.  Sex and the quality of life in Denmark.

Authors:  S Ventegodt
Journal:  Arch Sex Behav       Date:  1998-06

Review 5.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

6.  Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.

Authors:  Patrizia Ziccardi; Francesco Nappo; Giovanni Giugliano; Katherine Esposito; Raffaele Marfella; Michele Cioffi; Francesco D'Andrea; Anna Maria Molinari; Dario Giugliano
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

7.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

8.  Weight loss reduces interleukin-18 levels in obese women.

Authors:  Katherine Esposito; Alessandro Pontillo; Myriam Ciotola; Carmen Di Palo; Elisa Grella; Gianfranco Nicoletti; Dario Giugliano
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

9.  Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.

Authors:  Marek Straczkowski; Stella Dzienis-Straczkowska; Agnieszka Stêpieñ; Irina Kowalska; Malgorzata Szelachowska; Ida Kinalska
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

10.  A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.

Authors:  Subodh Verma; Chao-Hung Wang; Shu-Hong Li; Aaron S Dumont; Paul W M Fedak; Mitesh V Badiwala; Bikramjit Dhillon; Richard D Weisel; Ren-Ke Li; Donald A G Mickle; Duncan J Stewart
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

View more
  26 in total

Review 1.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

Review 2.  Abnormalities of Reproductive Function in Male Obesity Before and After Bariatric Surgery-A Comprehensive Review.

Authors:  Alberto Rosenblatt; Joel Faintuch; Ivan Cecconello
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

3.  Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis.

Authors:  Lianmin Luo; Qian Xiang; Yihan Deng; Shankun Zhao; Zhiguo Zhu; Yangzhou Liu; Jiamin Wang; Zhigang Zhao
Journal:  Rheumatol Int       Date:  2019-07-05       Impact factor: 2.631

Review 4.  Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training.

Authors:  Barbara J Nicklas; Tongjian You; Marco Pahor
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

5.  TNF-alpha knockout mice have increased corpora cavernosa relaxation.

Authors:  Fernando S Carneiro; Lashon C Sturgis; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; Brandi M Wynne; Sebastian San Martin; Michael W Brands; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2009-01       Impact factor: 3.802

Review 6.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

7.  The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Yunus Doğan; Fatih Uruç; Bekir Aras; Aytaç Şahin; Mithat Kıvrak; Ahmet Ürkmez; Numan Doğu Güner; Sabahattin Aydın
Journal:  Turk J Urol       Date:  2015-03

8.  TNF-alpha infusion impairs corpora cavernosa reactivity.

Authors:  Fernando S Carneiro; Saiprazad Zemse; Fernanda R C Giachini; Zidonia N Carneiro; Victor V Lima; R Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

9.  Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.

Authors:  Darshan P Patel; Jeannette M Schenk; Amy Darke; Jeremy B Myers; William O Brant; James M Hotaling
Journal:  BJU Int       Date:  2015-09-20       Impact factor: 5.588

10.  Sexual well-being and diurnal cortisol after prostate cancer treatment.

Authors:  Michael A Hoyt; Allison E Gaffey; Ashley W Wang; Mark S Litwin; Catalina J Lawsin
Journal:  J Health Psychol       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.